Press Releases

Date Title and Summary
Toggle Summary Accuray Reports Fiscal Third Quarter 2007 Financial Results
Click here for PDF version of this release Fiscal Third Quarter 2007 Highlights: -- Record revenue of $37.3 million, up 129 percent from the fiscal third quarter 2006 and up 42 percent from the fiscal second quarter 2007 -- Total backlog increased to $559 million, up 60 percent from the fiscal
Toggle Summary CyberKnife(R) Installed Base Reaches 100 Systems Worldwide as Field of Radiosurgery Continues to Expand
Total CyberKnife Patients Treated Rises to More Than 30,000 SUNNYVALE, Calif., May 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the CyberKnife(R) Robotic Radiosurgery System install base has reached 100 systems.
Toggle Summary Accuray Announces Conference Call to Discuss Amendments to Fiscal Third Quarter 2007 Financial Results
SUNNYVALE, Calif., May 14 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced it will conduct a live conference call and webcast for investors and analysts to discuss announced amendments to the Company's fiscal third quarter
Toggle Summary Accuray Amends Announcement of its Fiscal Third Quarter 2007 Financial Results
Click here for PDF version of this release Revenue, Operating Expenses, Cash Flows and Backlog Unaffected SUNNYVALE, Calif., May 14 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today issued an amended announcement of its fiscal third
Toggle Summary Health Technology Assessment Validates Extracranial Radiosurgery Treatments Particularly Those Delivered With CyberKnife(R)
French Health Authority Finds Clinical Benefits for Curative and Palliative Care SUNNYVALE, Calif., May 31 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the French High Authority of Health -- Haute Autorite de Sante
Toggle Summary Multiple Hospitals Acquire Second CyberKnife(R) System to Meet Growing Demand for Radiosurgery
Second CyberKnife Arrives at Georgetown University Hospital SUNNYVALE, Calif., June 6 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Georgetown University Hospital's second CyberKnife(R) Robotic Radiosurgery System
Toggle Summary 100 Percent of U.S. CyberKnife(R) Installed Base Treating Extracranial Tumors
Independent Data Confirms CyberKnife System is Only Radiosurgery Solution in Widespread Use for Extracranial Radiosurgery SUNNYVALE, Calif., June 20 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the latest utilization
Toggle Summary Accuray Incorporated to Present at Jefferies Healthcare Conference
SUNNYVALE, Calif., June 25 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Euan S. Thomson, Ph.D, president and chief executive officer and Robert E. McNamara, senior vice president and chief financial officer are
Toggle Summary Accuray Incorporated to Report Fiscal Fourth Quarter and Full Fiscal Year 2007 Financial Results on August 16, 2007
SUNNYVALE, Calif., July 16, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced it will report results for its fourth quarter fiscal year 2007 ending June 30, 2007 and full fiscal year 2007 ending
Toggle Summary Accuray's Xsight(TM) Lung Tracking System Gains Clinical Acceptance as U.S. Adoption Rate Exceeds 97 Percent
Monte Carlo Dose Calculation Extends CyberKnife(R) System's Capabilities in Precision Radiation Delivery for Lung Tumors SUNNYVALE, Calif., July 23 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Accuray's Xsight(TM)

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.